Researchers and Clinicians
A Letter of Intent is required prior to submission of a full-length proposal.
MoreIf invited to complete a full proposal, applicants must submit the form as a PDF to grants@atcp.org.
MoreThis trial in the Netherlands looked at the effects of nicotinamide ribose as a potential treatment for people with A-T.
MoreParticipants with A-T demonstrated lower brain activity or metabolism in the cerebellum as compared to control participants.
MoreAt the dose tested, Baclofen did not have a significant effect on tremor, eye movement or balance deficits.
MoreThis open label study was performed to assess the safety and tolerability of the EryDex System in people with A-T.
MoreThese trials studied whether a low dose betamethasone would reduce neurological symptoms associated with A-T.
MoreThis trial was performed to see if amantadine sulphate improves ataxia or other movement disorders associated with A-T.
MoreAmong the 204 identified CSF proteins, 13 showed significant changes in A-T patients versus control samples.
More